APS ACTION Mission

Mission

Primary Mission:
To prevent, treat, and cure antiphospholipid antibody (aPL) associated clinical manifestations through high-quality, multi-center, and multidisciplinary clinical research.

Secondary Mission:
To refine and advance the definitions of aPL associated clinical manifestations through international collaboration and data sharing.

Approach:
Members will work together to create a research alliance that will design and conduct clinical trials, and collect data via an international registry.